Emerging evidence emphasizes the strong impact of regulatory genomic elements in neurodevelopmental processes and the complex pathways of brain disorders. The present genome-wide quantitative trait loci analyses explore the cis-regulatory effects of single-nucleotide polymorphisms (SNPs) on DNA methylation (meQTL) and gene expression (eQTL) in 110 human hippocampal biopsies. We identify cis-meQTLs at 14,118 CpG methylation sites and cis-eQTLs for 302 3'-mRNA transcripts of 288 genes. Hippocampal cis-meQTL-CpGs are enriched in flanking regions of active promoters, CpG island shores, binding sites of the transcription factor CTCF and brain eQTLs. Cis-acting SNPs of hippocampal meQTLs and eQTLs significantly overlap schizophrenia-associated SN...
Human hippocampal volume has been separately associated with single nucleotide polymorphisms (SNPs),...
DNA methylation, which is modulated by both genetic factors and environmental exposures, may offer a...
Schizophrenia is a serious, complex psychiatric illness that affects around 1% of people globally, c...
Emerging evidence emphasizes the strong impact of regulatory genomic elements in neurodevelopmental ...
We have observed extensive interindividual differences in DNA methylation of 8590 CpG sites of 6229 ...
We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of ...
Identification of 108 genomic regions significantly associated with schizophrenia risk by the Psychi...
Understanding the difference in genetic regulation of gene expression between brain and blood is imp...
Research has shown that besides genes and environment, epigenetic factors are also playing a role in...
Recent studies suggest that genetic and environmental factors do not account for all the schizophren...
DNA methylation is a heritable modification of genomic DNA central to development, imprinting, trans...
A fundamental challenge in the post-genome era is to understand and annotate the consequences of gen...
Characterizing the complex relationship between genetic, epigenetic, and transcriptomic variation ha...
We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of ...
DNA methylation, which is modulated by both genetic factors and environmental exposures, may offer a...
Human hippocampal volume has been separately associated with single nucleotide polymorphisms (SNPs),...
DNA methylation, which is modulated by both genetic factors and environmental exposures, may offer a...
Schizophrenia is a serious, complex psychiatric illness that affects around 1% of people globally, c...
Emerging evidence emphasizes the strong impact of regulatory genomic elements in neurodevelopmental ...
We have observed extensive interindividual differences in DNA methylation of 8590 CpG sites of 6229 ...
We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of ...
Identification of 108 genomic regions significantly associated with schizophrenia risk by the Psychi...
Understanding the difference in genetic regulation of gene expression between brain and blood is imp...
Research has shown that besides genes and environment, epigenetic factors are also playing a role in...
Recent studies suggest that genetic and environmental factors do not account for all the schizophren...
DNA methylation is a heritable modification of genomic DNA central to development, imprinting, trans...
A fundamental challenge in the post-genome era is to understand and annotate the consequences of gen...
Characterizing the complex relationship between genetic, epigenetic, and transcriptomic variation ha...
We characterized DNA methylation quantitative trait loci (mQTLs) in a large collection (n = 166) of ...
DNA methylation, which is modulated by both genetic factors and environmental exposures, may offer a...
Human hippocampal volume has been separately associated with single nucleotide polymorphisms (SNPs),...
DNA methylation, which is modulated by both genetic factors and environmental exposures, may offer a...
Schizophrenia is a serious, complex psychiatric illness that affects around 1% of people globally, c...